Editor's Pick: Bladder Cancer
Interview with:
Angela B. Smith, MD, MS, FACS
Associate Professor of Urology
Director of Urologic Oncology
University of North Carolina- Chapel Hill
Interviewed by John W. Davis, MD
The University of Texas M.D. Anderson Cancer Center
Houston, Texas
Referenced articles:
Check DK, Leo MC, Banegas MP et al: Decision regret related to urinary diversion choice among patients treated with cystectomy. J Urol 2020; 203: 159.
https://doi.org/10.1097/JU.0000000000000512
Ritch CR, Velasquez MC, Kwon D et al: Use and validation of the AUA/SUO risk grouping for nonmuscle invasive bladder cancer in a contemporary cohort. J Urol 2020; 203: 505.
https://doi.org/10.1097/JU.0000000000000593
Margulis V, Puligandla M, Trabulsi EJ et al: Phase II trial of neoadjuvant systemic chemotherapy followed by extirpative surgery in patients with high grade upper tract urothelial carcinoma. J Urol 2020; 203: 690.
https://doi.org/10.1097/JU.0000000000000644
Recorded April 30, 2020
